OTHER LONG-TERM LIABILITIES

3 Months Ended

Mar. 31, 2021

7. OTHER LONG-TERM LIABILITIES

Other long-term liabilities consists of the following:


	March 31, 2021		December 31, 2020
Technology Investment Agreement (TIA)	$	31,378,662	$	22,444,324
Stock repurchase		1,004,888		2,034,373
Total	$	32,383,550	$	24,478,697

The TIA provides for reimbursement to the Company for the purchase of equipment and supplies related to the expansion of the Company’s domestic production of needles and syringes. Under the TIA, reimbursable amounts will be reflected as a liability until the time its deferred income can be systematically amortized over a period matching the useful life of the purchased assets.

The stock repurchase liability represents the long-term portion, at net present value, of $2,057,823 gross payable by the Company to former preferred shareholders as a result of private stock purchases in 2020 of 320,333 shares of Class B Series IV preferred stock and 25,000 shares of Class B Series V preferred stock. The purchase price is payable in three annual installments of $1,101,110.